Japanese researchers suggest that complex cases of chronic total occlusion (CTO) with bifurcation at the distal cap can be treated successfully using refined strategies, especially with use of the retrograde approach. 

The association between social determinants of health (SDOH) and increased rates of death due to cardiovascular disease (CVD) is mediated by behavioral and clinical risk factors, a new survey study shows. 

Calprotectin may be a biomarker for atherosclerotic cardiovascular disease (ASCVD), a new study shows. 

The degree of ischemia detected on dobutamine stress echocardiography (DSE) strongly predicts the efficacy of percutaneous coronary intervention (PCI) in patients with stable coronary artery disease (CAD), according to a new analysis from the ORBITA-2 trial. 

King and I | S6 E1 | Quality of Life Measures in Asymptomatic TAVR Patients & Device Approvals

Contrast volume used during percutaneous coronary intervention (PCI) has shown a consistent but modest decline between 2018 and 2022, with less contrast used in patients at higher risk for acute kidney injury (AKI), according to a new analysis of national registry data. 

New research suggests that rapid uptitration of guideline-directed medical therapy (GDMT) in patients hospitalized for acute heart failure (HF) significantly increases the number of days patients were free of death or HF rehospitalization. 

A comprehensive new set of performance and quality measures for chronic coronary disease (CCD) will enhance the care of millions of patients through standardized metrics, according to a joint report from the American Heart Association (AHA) and American College of Cardiology (ACC). 

New research sheds light on the impact of obesity and insulin resistance (IR) on heart abnormalities in patients with heart failure with preserved ejection fraction (HFpEF).